Nancy Buese - 21 Feb 2025 Form 4 Insider Report for Baker Hughes Co (BKR)

Reporting relationship: EVP & Chief Financial Officer
Issuer ticker: BKR
Reported as of: 21 Feb 2025
Net transaction value: -$3,709,600
SEC form: 4
Accepted by SEC: 25 Feb 2025, 19:09:24 UTC
Prior SEC filing: 05 Feb 2025
Next SEC filing: 12 May 2025
Source filing: View source filing
Reporting owner signature: /s/ Fernando Contreras, Attorney-in-fact

Key filing fact

Nancy Buese filed Form 4 for Baker Hughes Co (BKR) on 25 Feb 2025.

Key facts

This page summarizes Nancy Buese's Form 4 filing for Baker Hughes Co (BKR).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 25 Feb 2025, 19:09.

Change

Previous filing in this sequence was filed on 05 Feb 2025.
Current net transaction value: -$3,709,600.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BKR transaction

Class A Common Stock

Sale

Transaction value: $3,709,600
Shares: -80,000
Change %: -93%
Price: $46.37
Shares after: 6,299
Date: 21 Feb 2025
Ownership: By trust
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Section 16 status

Nancy Buese is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

This transaction is pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 21, 2024.

Footnote F2

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.86 to $46.73, inclusive. Details on the number of shares sold at each separate price will be provided to the Issuer, any shareholder of the Issuer, or staff of the Securities and Exchange Commission upon request.